Tmed5-flox Mouse

TMED5, also known as transmembrane P24 trafficking protein 5, is involved in multiple biological processes. In mammals, it may be related to immune response, signal transduction, growth, and disease development [4]. Although its exact essential function and associated pathways are still being explored, studies suggest it could play a role in pathways like the mammalian target of rapamycin and transforming growth factor beta signaling pathways [1].

In hepatocellular carcinoma (HCC), TMED5 mRNA is highly expressed in HCC tissues compared to adjacent normal tissues. Silencing TMED5 in SMMC-7721 and Hep3B cells suppressed cell proliferation, migration, and invasion, while enhancing apoptosis, indicating its potential role in promoting HCC progression [1].

In gastric cancer, the TP73-AS1/miR-27b-3p/TMED5 axis was found to regulate the wnt/β-catenin pathway, with TMED5 up-regulated and promoting cancer cell proliferation, migration, and invasion [2].

In cervical cancer, a circ_0018289/miR-183-5p/TMED5 regulatory network was identified, where circ_0018289 induced TMED5 expression by competitively binding to miR-183-5p, and TMED5 promoted cancer development and angiogenesis [3].

In conclusion, TMED5 seems to play a role in promoting the progression of several cancers, including HCC, gastric cancer, and cervical cancer. These findings from cell-based functional studies provide insights into the role of TMED5 in disease conditions, suggesting that it could potentially be a therapeutic target for these cancers.